Over the course of nearly five decades, Biogen has played a major role in catalyzing and shaping Kendall Square in Cambridge, Massachusetts, now heralded as the “most innovative square mile on the planet.” Today, Biogen announced its decision to centralize operations in a new facility at 75 Broadway in MIT’s Kendall Common development. The move, which will take place in 2028, highlights the company’s commitment to Cambridge and the regional innovation ecosystem — a wellspring of biomedical advances.“It’s fitting that Biogen — a company with such close ties to people…
